Pharmlog Pharma Logistik
Pharmlog Pharma Logistik, commonly referred to as Pharmlog, is a leading logistics provider in the pharmaceutical industry, headquartered in Germany. Established in 2003, the company has rapidly expanded its operations across Europe, specialising in temperature-controlled logistics and supply chain solutions tailored for the healthcare sector. Pharmlog offers a range of core services, including warehousing, distribution, and regulatory compliance, ensuring the safe and efficient delivery of pharmaceutical products. Their commitment to quality and innovation has positioned them as a trusted partner for numerous pharmaceutical companies. With a focus on maintaining the integrity of sensitive products, Pharmlog has achieved significant milestones, reinforcing its reputation as a key player in the pharmaceutical logistics market.
DitchCarbon Score
How does Pharmlog Pharma Logistik's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmlog Pharma Logistik's score of 37 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmlog Pharma Logistik's reported carbon emissions
In 2023, PharmLog Pharma Logistik reported total carbon emissions of approximately 4,698,000 kg CO2e. This figure includes 389,200 kg CO2e from Scope 1 emissions and a significant 4,308,600 kg CO2e from Scope 3 emissions, which encompasses various categories such as employee commuting and downstream transportation. Comparatively, in 2022, the company’s total emissions were about 6,692,000 kg CO2e, indicating a reduction of approximately 1,994,000 kg CO2e year-on-year. This reduction reflects PharmLog's commitment to improving its environmental impact. PharmLog has set ambitious targets to further reduce its greenhouse gas emissions. The company aims to achieve a 46% reduction in Scope 1 and Scope 2 emissions by 2030, using 2019 as the baseline year. This target has been validated by the Science Based Targets initiative (SBTi) and is aligned with the goal of limiting global warming to 1.5°C. Additionally, PharmLog is committed to measuring and reducing its Scope 3 emissions, which are critical given their substantial contribution to the overall emissions profile. The emissions data for PharmLog is cascaded from its parent company, Viatris Inc., reflecting a corporate family relationship that influences its sustainability strategies. As a small to medium enterprise (SME) in the healthcare sector, PharmLog is actively working towards enhancing its climate commitments and reducing its carbon footprint in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 365,800 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,290,000 | - | - | - |
| Scope 3 | 6,180,900 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmlog Pharma Logistik is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
